EMEA-002217-PIP01-17-M02

Table of contents

Key facts

Active substance
In vitro expanded autologous human articular chondrocytes
Therapeutic area
Other
Decision number
P/0315/2021
PIP number
EMEA-002217-PIP01-17-M02
Pharmaceutical form(s)
Implant
Condition(s) / indication(s)
Treatment of cartilage disorders
Route(s) of administration
Intraarticular use
Contact for public enquiries
TETEC Tissue Engineering Technologies AG

E-mail: info@tetec-ag.de
Tel: +49 712116260

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating